Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Max Healthcare Institute's 9-Day RSI or its related term are showing as below:
NSE:MAXHEALTH's 9-Day RSI is ranked better than 93.54% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 50.06
vs NSE:MAXHEALTH: 27.81
Max Healthcare Institute (NSE:MAXHEALTH) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Max Healthcare Institute 9-Day RSI Related Terms
NSE:MAXHEALTH vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Max Healthcare Institute's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Max Healthcare Institute 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Max Healthcare Institute's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Max Healthcare Institute's 9-Day RSI falls into.
Max Healthcare Institute (NSE:MAXHEALTH) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Max Healthcare Institute (NSE:MAXHEALTH) has a 9-Day RSI of 27.81 as of Aug. 24, 2026. According to the industry distribution chart, Max Healthcare Institute ranks #45 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 6.5%.
Is Max Healthcare Institute's 9-Day RSI too high?
Max Healthcare Institute's current 9-Day RSI is 27.81. The Healthcare Providers & Services industry median 9-Day RSI is 50.06. Max Healthcare Institute's value of 27.81 is 44.4% below this industry median. Based on the distribution chart, Max Healthcare Institute ranks #45 out of 697 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Max Healthcare Institute has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Max Healthcare Institute's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Max Healthcare Institute ranks #45 out of 697 companies for 9-Day RSI. This places Max Healthcare Institute in the top 7% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 50.06. Max Healthcare Institute's value of 27.81 is 44.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 50.06, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Max Healthcare Institute's current 9-Day RSI of 27.81 is 44.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 50.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Max Healthcare Institute's current 9-Day RSI is 27.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max Healthcare Institute stock overvalued right now?
Based on GuruFocus' analysis, Max Healthcare Institute (NSE:MAXHEALTH) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,434.33, compared to a current price of ₹1,000.00 — trading 30.3% below its estimated fair value. The current 9-Day RSI is 27.81 and 44.4% below the Healthcare Providers & Services industry median of 50.06. Max Healthcare Institute's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Max Healthcare Institute (NSE:MAXHEALTH), the current 9-Day RSI is 27.81 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Max Healthcare Institute (NSE:MAXHEALTH) Overvalued in 2026?
Based on GuruFocus' analysis, Max Healthcare Institute stock appears to be undervalued.
The current stock price of ₹1,000.00 is trading 30.3% below its estimated GF Value™ of ₹1,434.33.
GuruFocus considers Max Healthcare Institute to be Significantly Undervalued.
Key valuation signals for NSE:MAXHEALTH:
9-Day RSI: 27.81
GF Value™: ₹1,434.33 vs. price of ₹1,000.00 (30.3% below fair value)
Industry Position: 44.4% below the Healthcare Providers & Services median (#45 of 697)
No single metric tells the full story. See the NSE:MAXHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
92GF Score
Get the complete analysis for NSE:MAXHEALTH
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MAXHEALTH has been successfully added to your 
